Andrew Marr assesses more announcements from EMA on EVMPD

Andrew Marr re-assesses the impact of the revised guidance on EVMPD issued by EMA on 1September¬† 2011 together with key information provided at the EMA’s Information Day on EVMPD held on 22 September 2011.

EVMPD data are required to be submitted to EMA for all authorised medicinal products in Europe by 2 July 2012.

Click here to view the journal article. Journal Article

This article was published in the October 2011 issue of Scrip Regulatory Affairs.